Biolog-id Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 100
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 1

Biolog-id General Information

Description

Manufacturer of traceability products intended to manage and trace sensitive health products. The company's products are designed as health products and processes such as labile blood components, plasma for fractionation and chemotherapy injectables, contain a radio frequency identification tag connected with a database, and smart storage units, enabling hospitals and transfusion centers to manage the transfusion, plasma, and chemotherapy supply chain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Delivery
Other Healthcare Technology Systems
Primary Office
  • 46, rue du Général Leclerc
  • 92100 Boulogne-Billancourt
  • France
+33 01 00 00 00 00

Biolog-id Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolog-id Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Jul-2021 0000 Completed Generating Revenue
5. Later Stage VC 19-Nov-2019 000.00 0000 00000 Completed Generating Revenue
4. Later Stage VC 08-Nov-2016 00.00 00.00 Completed Generating Revenue
3. Later Stage VC 30-Apr-2015 Completed Generating Revenue
2. Later Stage VC 01-May-2011 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2010 Completed Generating Revenue
To view Biolog-id’s complete valuation and funding history, request access »

Biolog-id Patents

Biolog-id Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210342558-A1 Dispenser for controlling a medical product container, and associated assembly, facility and control method Pending 12-Oct-2018 00000000000
FR-3087291-A1 Mobile terminal for controlling a container of a medical product, assembly, installation and method for controlling the same Granted 12-Oct-2018 000000000 0
FR-3087291-B1 Mobile terminal for controlling a medical product container, assembly, installation and associated control procedure Active 12-Oct-2018 000000000
JP-2020500041-A Device for storing elements Pending 03-Oct-2016 000000000 0
EP-3520089-A1 Device for storing elements Granted 03-Oct-2016 A61J1/10
To view Biolog-id’s complete patent history, request access »

Biolog-id Executive Team (8)

Name Title Board Seat Contact Info
Bruno Chappert Chief Executive Officer & President
Troy Hilsenroth Global Chief Executive Officer
Arnaud Saint-Michel Chief Financial Officer
Amit Mayer CIO
Jean-Claude Mongrenier Founder, President & Vice-President of the Supervisory board
You’re viewing 5 of 8 executive team members. Get the full list »

Biolog-id Board Members (3)

Name Representing Role Since
Dominik Belloin Biolog-id Board Member 000 0000
Jean-Luc Belingard Biolog-id Chairman of Supervisory Board 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Biolog-id Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolog-id Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Xerys Invest PE/Buyout Minority 000 0000 000000 0
To view Biolog-id’s complete investors history, request access »

Biolog-id Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000000 Other Healthcare Technology Systems
To view Biolog-id’s complete investments history, request access »